RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers

Endometrioid and serous endometrial cancers are underpinned by distinct molecular pathways. MSH6 expression levels may be associated with outcome in endometrial cancers as a group.